Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer.

Novel imidazoacridinone derivatives, C1310 and C1311, have been evaluated for their potential to inhibit tumour cell growth in vitro and in vivo. A cell line panel, including seven human and murine colon carcinoma cell lines and three in vivo models, was used. The compounds were found to be potent i...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, A. M., Double, J. A., Konopa, J., Bibby, M. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074789/
https://www.ncbi.nlm.nih.gov/pubmed/8912531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074789/
https://www.ncbi.nlm.nih.gov/pubmed/8912531

Ejemplares similares